ECO 2025 11 - 14 May 2025

Early Clinical Benefit of Semaglutide in Adults with Overweight or Obesity and Cardiovascular Disease: A Secondary Analysis of the SELECT Trial

Authors :

Jorge Plutzky¹; John W. Ostrominski¹; Vanita R. Aroda²; John Deanfield³; Scott S. Emerson⁴; G. Kees Hovingh⁵; Steven E. Kahn⁶; Sergio Leonardi⁷; Ildiko Lingvay⁸; Donna H. Ryan⁹; Søren Rasmussen⁵; Benjamin M. Scirica¹⁰; Signe Stensen⁵; Peter E. Weeke⁵; A. Michael Lincoff¹¹

Affiliations

View Details Hide Details

Keywords

Obesity

Cardiovascular Disease

Congress oral presentation

GLP-1 RA

Semaglutide

PHASE 3 (RCT)

Search Science Hub

Are you a healthcare professional?

Early Clinical Benefit of Semaglutide in Adults with Overweight or Obesity and Cardiovascular Disease: A Secondary Analysis of the SELECT Trial